EP3407884
TARGETING CHROMATIN REGULATORS FOR INHIBITING LEUKEMOGENIC GENE EXPRESSION IN NPM1
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
26.1.2017EP published:
9.7.2025EP application number:
17744904.8
EPO information:
European Patent Register
Max expiry date:
25.1.2037
Title in English:
TARGETING CHROMATIN REGULATORS FOR INHIBITING LEUKEMOGENIC GENE EXPRESSION IN NPM1Language of the patent:
English
Timeline
Today
26.1.2017EP application
9.7.2025EP Publication
Owner
Name:
Memorial Sloan-Kettering Cancer CenterAddress:
1275 York Avenue, New York, NY 10021, US
Inventor
Name:
ARMSTRONG, Scott, A.Address:
New York NY 10021, US
Priority
Number:
201662287419 PDate:
26.1.2016Country:
US
Number:
201662370670 PDate:
3.8.2016Country:
US
Classification
Categories:
A61K 31/519, A61K 31/7064, A61P 35/02